topotecan has been researched along with Fecal Impaction in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chow, A; Emmenegger, U; Francia, G; Kerbel, RS; Man, S; Wong, A | 1 |
1 other study(ies) available for topotecan and Fecal Impaction
Article | Year |
---|---|
Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy.
Topics: Administration, Metronomic; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclophosphamide; Docetaxel; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Fecal Impaction; Gene Expression Regulation, Neoplastic; Gene Ontology; Humans; Male; Mice; Mice, Nude; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Taxoids; Topotecan; Up-Regulation; Xenograft Model Antitumor Assays | 2014 |